Is Neuraxis, INC (NRXS) Halal?

NYSE Healthcare United States $77M
✗ NOT HALAL
Confidence: 90/100
Neuraxis, INC (NRXS) is Not Halal under AAOIFI Standard 21. The company's impermissible income ratio of 20.59% exceeds the 5% threshold allowed under AAOIFI. Neuraxis, INC operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 0.8%
/ 30%
6.1%
/ 30%
0.4%
/ 30%
20.59%
/ 5%
✗ NOT HALAL
DJIM 0.8%
/ 33%
6.1%
/ 33%
0.4%
/ 33%
20.59%
/ 5%
✗ NOT HALAL
MSCI 10.0%
/ 33%
77.7%
/ 33%
5.1%
/ 33%
20.59%
/ 5%
✗ NOT HALAL
S&P 0.8%
/ 33%
6.1%
/ 33%
0.4%
/ 33%
20.59%
/ 5%
✗ NOT HALAL
FTSE 10.0%
/ 33%
77.7%
/ 33%
5.1%
/ 50%
20.59%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-0.95
P/B Ratio
21.6
EV/EBITDA
-10.2
EV: $73M
Revenue
$3M
Growth: 27.2%
Beta
2.5
High volatility
Current Ratio
2.1

Profitability

Gross Margin 84.2%
Operating Margin -177.3%
Net Margin -218.5%
Return on Equity (ROE) -285.4%
Return on Assets (ROA) -80.6%

Cash Flow & Balance Sheet

Operating Cash Flow-$6M
Free Cash Flow-$6M
Total Debt$473,405
Debt-to-Equity12.6
Current Ratio2.1
Total Assets$5M

Price & Trading

Last Close$7.00
50-Day MA$5.55
200-Day MA$3.53
Avg Volume157K
Beta2.5
52-Week Range
$1.33
$7.97

About Neuraxis, INC (NRXS)

CEO
Mr. Brian Carrico
Employees
24
Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
NYSE
Market Cap
$77M
Currency
USD

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Neuraxis, INC (NRXS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Neuraxis, INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Neuraxis, INC's debt ratio?

Neuraxis, INC's debt ratio is 0.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 10.0%.

What are Neuraxis, INC's key financial metrics?

Neuraxis, INC has a market capitalization of $77M, and revenue of $3M. The company maintains a gross margin of 84.2% and a net margin of -218.5%. Return on equity stands at -285.4%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.